Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation.
Binayke A; Zaheer A; Vishwakarma S; Singh S; Sharma P; Chandwaskar R; Gosain M; Raghavan S; Murugesan DR; Kshetrapal P; Thiruvengadam R; Bhatnagar S; Pandey AK; Garg PK; Awasthi A.
NPJ Vaccines
(Unknown)
Published: 2024
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells.
Zimmermann J; van Haren SD; Diray-Arce J; Adriawan IR; Wørzner K; Krog RT; Guleed S; Hu T; Mortensen R; Dietrich J; Solbak SMØ; Levy O; Christensen D; Pedersen GK.
NPJ Vaccines
(Unknown)
Published: 2023
A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax.
Kunkeaw N; Nguitragool W; Takashima E; Kangwanrangsan N; Muramatsu H; Tachibana M; Ishino T; Lin PJC; Tam YK; Pichyangkul S; Tsuboi T; Pardi N; Sattabongkot J.
NPJ Vaccines
(Unknown)
Published: 2023
Healthy ageing: Herpes zoster infection and the role of zoster vaccination.
NPJ Vaccines
(Unknown)
Published: 2023
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza…
Swart M; Kuipers H; Milder F; Jongeneelen M; Ritschel T; Tolboom J; Muchene L; van der Lubbe J; Izquierdo Gil A; Veldman D; Huizingh J; Verspuij J; Schmit-Tillemans S; Blokland S; de Man M; Roozendaal R; Fox CB; Schuitemaker H; Capelle M; Langedijk JPM; Zahn R; Brandenburg B.
NPJ Vaccines
(Unknown)
Published: 2023
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys.
Boopathy AV; Sharma B; Nekkalapudi A; Wimmer R; Gamez-Guerrero M; Suthram S; Truong H; Lee J; Li J; Martin R; Blair W; Geleziunas R; Orlinger K; Ahmadi-Erber S; Lauterbach H; Makadzange T; Falkard B; Schmidt S.
NPJ Vaccines
(Unknown)
Published: 2023
Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a c…
Maloney BE; Carpio KL; Bilyeu AN; Saunders DRD; Park SL; Pohl AE; Ball NC; Raetz JL; Huang CY; Higgs S; Barrett ADT; Roman-Sosa G; Kenney JL; Vanlandingham DL; Huang YS.
NPJ Vaccines
(Unknown)
Published: 2023
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants.
Mittal N; Kumar S; Rajmani RS; Singh R; Lemoine C; Jakob V; Bj S; Jagannath N; Bhat M; Chakraborty D; Pandey S; Jory A; Sa SS; Kleanthous H; Dubois P; Ringe RP; Varadarajan R.
NPJ Vaccines
(Unknown)
Published: 2023
Key advances in vaccine development for tuberculosis-success and challenges.
NPJ Vaccines
(Unknown)
Published: 2023
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ viru…
Carboni F; Cozzi R; Romagnoli G; Tuscano G; Balocchi C; Buffi G; Bodini M; Brettoni C; Giusti F; Marchi S; Brogioni G; Brogioni B; Cinelli P; Cappelli L; Nocciolini C; Senesi S; Facciotti C; Frigimelica E; Fabbrini M; Stranges D; Savino S; Maione D; Adamo R; Wizel B; Margarit I; Romano MR.
NPJ Vaccines
(Unknown)
Published: 2023
Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and prot…
Cheung M; Chang C; Rathnasinghe R; Rossignol E; Zhang Y; Ferrari A; Patel H; Huang Y; Sanchez Guillen M; Scalzo T; Lee C; Otten GR; Settembre EC; Music N; Palladino G; Wen Y.
NPJ Vaccines
(Unknown)
Published: 2023
Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vacc…
Vinzón SE; Lopez MV; Cafferata EGA; Soto AS; Berguer PM; Vazquez L; Nusblat L; Pontoriero AV; Belotti EM; Salvetti NR; Viale DL; Vilardo AE; Avaro MM; Benedetti E; Russo ML; Dattero ME; Carobene M; Sánchez-Lamas M; Afonso J; Heitrich M; Cristófalo AE; Otero LH; Baumeister EG; Ortega HH; Edelstein A; Podhajcer OL.
NPJ Vaccines
(Unknown)
Published: 2023
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.
Leal L; Pich J; Ferrer L; Nava J; Martí-Lluch R; Esteban I; Pradenas E; Raïch-Regué D; Prenafeta A; Escobar K; Pastor C; Ribas-Aulinas M; Trinitè B; Muñoz-Basagoiti J; Domenech G; Clotet B; Corominas J; Corpes-Comes A; Garriga C; Barreiro A; Izquierdo-Useros N; Arnaiz JA; Soriano A; Ríos J; Nadal M; Plana M; Blanco J; Prat T; Torroella E; Ramos R; HIPRA-HH-1 study group.
NPJ Vaccines
(Unknown)
Published: 2023